These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24140751)

  • 1. Quantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwash.
    Pierce Campbell CM; Guan W; Sprung R; Koomen JM; O'Keefe MT; Ingles DJ; Abrahamsen M; Giuliano AR
    J Immunol Methods; 2013 Dec; 400-401():117-21. PubMed ID: 24140751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
    Dickey BL; Sirak B; Martin-Gomez L; Reich RR; Abrahamsen M; Isaacs-Soriano K; Chung CH; Giuliano AR
    PLoS One; 2021; 16(7):e0254161. PubMed ID: 34214131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
    Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.
    Rahman S; Pierce Campbell CM; Torres BN; O'Keefe MT; Ingles DJ; Villa LL; Carvalho da Silva RJ; Cintra RC; Lazcano-Ponce E; Salmeron J; Quiterio M; Giuliano AR
    Oral Dis; 2016 Nov; 22(8):781-790. PubMed ID: 27470907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
    Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
    Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
    Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
    J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
    J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
    Shugars DC; Watkins CA; Cowen HJ
    Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
    Lin AL; Johnson DA; Stephan KT; Yeh CK
    J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
    Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
    Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
    Sahin E; Madendag Y; Sahin ME; Madendag IC; Acmaz G; Karakukcu C; Karaman H; Muderris II
    Cancer Control; 2018; 25(1):1073274818798598. PubMed ID: 30180755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
    Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
    Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma.
    Quabius ES; Görögh T; Fischer GS; Hoffmann AS; Gebhard M; Evert M; Beule A; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Röcken C; Hedderich J; Ambrosch P; Hoffmann M
    Cancer Lett; 2015 Feb; 357(1):339-345. PubMed ID: 25462861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.
    Pushpanshu K; Sathawane RS; Kaushik R
    Indian J Palliat Care; 2014 Jan; 20(1):26-30. PubMed ID: 24600179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
    Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
    BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of smoking habit, SLPI and AnxA2 in HPV associated head and neck and other cancers.
    Hoffmann M; Quabius ES; Fabian A; Laudien M; Ambrosch P
    Cancer Treat Res Commun; 2021; 26():100299. PubMed ID: 33387869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.